KRYS · Krystal Biotech, Inc. · Share Buybacks
$347.00
+1.45 (+0.42%)
At close · Sep 11
Market Cap
$10.23B
Shares
29.60M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | $150,000,000 | — | 2026-04-06 expired | 10-K , filed 2026-02-17 |
Key facts
CIK
1711279
CUSIP
501147102
13F (30d)
161 filings
160 filers
Visit website
Investor relations